EMA Authorised: Entresto (sacubitril;valsartan) — Novartis Europharm Limited

View source ↗

Summary

The EMA authorised Entresto (sacubitril/valsartan) for heart failure in the European Union. The Marketing Authorization Holder is Novartis Europharm Limited; de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Status: Authorised. Therapeutic area: Heart Failure. MAH: Novartis Europharm Limited. Decision date: 12/01/2026